Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label biomarker pilot study of denosumab in pre-operative early breast cancer
2016-002678-11Phase 3Active
- Sponsor
- Institut Català d'Oncologia
- Start
- Apr 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of denosumab in breast cancer, sponsored by Institut Català d'Oncologia. Primary endpoint: Change in Ki67 and cleaved caspase-3 expression. Started Apr 2018; status: active.
02
Drugs
denosumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2016-002678-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002678-11.